What exactly does Remicade do

Remicade (infliximab) is a chimeric IgG1k monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, Crohn’s disease, and ankylosing spondylitis. Remicade is also used to treat severe or disabling plaque psoriasis (raised, silvery flaking of the skin).

What does Remicade do to your body?

Infliximab works by blocking the actions of a certain natural substance (tumor necrosis factor alpha) in the body. This helps to decrease swelling (inflammation) and weaken your immune system, which slows or stops the damage from the disease.

Is weight gain a side effect of Remicade?

Remicade may cause heart failure in people who don’t have risk factors for heart problems. Seek emergency medical attention if you develop symptoms of heart failure while using Remicade. Symptoms include sudden weight gain, swelling of the ankles or feet, and shortness of breath.

Why is Remicade bad for you?

People who take Remicade have an increased risk for serious infections that may lead to a hospital stay or death. These include tuberculosis (TB), fungal infections throughout the body, and other bacterial and viral infections.

How long can you stay on Remicade?

There is no limit on the amount of time a patient can take Remicade (infliximab). The drug has been available since 1998, and many patients have been successfully treated and have been on Remicade for more than six years.

How will I feel after Remicade infusion?

Reactions can occur after the Remicade infusion. Symptoms generally include muscle or joint aches, itching, rash, fever and fatigue. These symptoms can be relieved by taking acetaminophen, antihistamines and/or steroids.

What are the serious side effects of Remicade?

pain or swelling at injection site,
joint or muscle pain,
swelling of ankles or feet,
easy bruising or bleeding,
vision changes,
seizures,
confusion,
muscle weakness,

Is Remicade safe long term?

Long-term use of Remicade may cause severe liver disease, including liver failure, hepatitis, and blockage of enzymes from your liver. Some of these enzymes are needed to process certain drugs. Blockage can lead to higher levels of these drugs in your body and lead to more side effects.

Does Remicade cause hair loss?

Remicade didn’t cause hair loss in people who took the medication in clinical studies. However, hair loss has been reported in people who took other tumor necrosis factor-alpha (TNF-alpha) inhibitors.

What happens when you stop taking Remicade?

Quitting your medication can reverse a remission and cause a flare-up of symptoms, including diarrhea, stomach pain, cramps, fatigue, bloody stools, mouth sores, and weight loss. You may also have joint or back pain, vision changes, or fever. It can damage your gastrointestinal tract.

Article first time published on

Is Remicade an immunotherapy?

Infliximab is a type of monoclonal antibody drug that is classified as a biologic. This drug acts as an immunosuppressant drug and is commonly used to treat autoimmune diseases such as ankylosing spondylitis, Crohn’s disease, rheumatoid arthritis (RA), ulcerative colitis (UC), psoriasis, and psoriatic arthritis.

Can I drink alcohol while on Remicade?

A drink or two shouldn’t be a problem if you’re on a biologic drug like adalimumab (Humira) or infliximab (Remicade). “There’s no real interaction with alcohol, so those all should be safe,” Swanson says. You do need to be cautious when you take immunomodulators like azathioprine (Azasan) and methotrexate, though.

Does Remicade lower your immune system?

REMICADE can lower the ability of your immune system to fight infections. Serious infections have happened in patients receiving REMICADE. These infections include tuberculosis (TB) and infections caused by viruses, fungi or bacteria that have spread throughout the body.

Can Remicade cure fistulas?

REMICADE is also indicated for reducing the number of draining enterocutaneous and rectovaginal fistulas and maintaining fistula closure in patients with fistulizing CD. Many people with heart failure should not take REMICADE; so, prior to treatment, patients should discuss any heart condition with their doctor.

How do you know if Remicade has stopped working?

If the Prometheus test reports a normal trough level of Remicade with little to no antibodies present, and the patient’s condition doesn’t stabilize or improve, then the medication is no longer therapeutic.

Can Remicade cure Crohn's?

Remicade® (infliximab) is a treatment option for patients who suffer from inflammatory bowel diseases, such as ulcerative colitis and Crohn’s disease, who have not responded to other drug therapies. The drug is also used to treat various joint disorders as well as psoriasis.

How much does Remicade infusion cost?

How Much Does Remicade Cost? A single dose of Remicade can cost from $1,300 to $2,500. The first step is determining insurance coverage for the infusion. Medicare does cover Remicade infusions.

How quickly does Remicade work?

Some people report an improvement in symptoms after a few days, others up to 6 weeks after their first infusion.

Can Remicade cause heart failure?

Higher incidences of mortality and hospitalisation for worsening heart failure were seen in those patients treated with Remicade, especially those treated with the higher dose of 10 mg/ kg.

What should I do before REMICADE infusion?

The day before the infusion, drink plenty of water to be sure you are well hydrated during the infusion. This is believed to make IV’s easier to insert and reduce infusion reactions. Maybe you can also buy a bottle of your favorite water or juice to bring with you to the infusion.

Does REMICADE have mouse protein?

REMICADE contains the active ingredient, infliximab. Infliximab is a monoclonal antibody that is produced from human and mouse proteins by recombinant technology. Monoclonal antibodies are proteins that recognise and bind to certain special proteins in the body.

Is REMICADE used to treat sarcoidosis?

Summary. REMICADE is not approved by the FDA for the treatment of sarcoidosis. Controlled trials, retrospective studies, open-label studies, and case reports have described the use of infliximab in the treatment of sarcoidosis.

Can you take ibuprofen with Remicade?

No interactions were found between ibuprofen and Remicade. This does not necessarily mean no interactions exist. Always consult your healthcare provider.

What's the difference between Remicade and Humira?

Remicade is given as an intravenous infusion that must be administered by a healthcare professional. Humira, on the other hand, is administered as a single-use pen or syringe injection that can be given at home. Both Remicade and Humira have similar side effects and drug interactions.

Does infliximab make you tired?

Infliximab may also cause side effects such as headaches, abdominal pain, nausea, joint pain, and fatigue, eye problems and depression.

How often is Remicade given?

The recommended dosage of REMICADE® is 5 mg/kg given as an intravenous induction regimen at 0, 2, and 6 weeks, followed by a maintenance regimen of 5 mg/kg every 8 weeks thereafter for the treatment of active PsA.

Can Remicade cause lupus?

Summary. Treatment with REMICADE may result in the formation of autoantibodies and in the development of a lupus-like syndrome. If a patient develops symptoms suggestive of a lupus-like syndrome following treatment with REMICADE, treatment should be discontinued.

Can Remicade cause MS?

Drugs generally do not cause MS, though there have been rare exceptions. Certain drugs used for rheumatoid arthritis or Crohn’s disease–for example, etanercept (Enbrel) and infliximab (Remicade)–have produced the symptoms and findings of MS.

How do you get colitis into remission?

Prescription medications, as well as some lifestyle and dietary changes, can help people with UC to maintain remission. A person is likely to benefit from managing stress, exercising regularly, and taking care to avoid food triggers. Certain supplements may also help prevent UC flare-ups.

Can you go back on Remicade after stopping?

For example, the STORI study, which was conducted by Dr Edouard Louis and colleagues and published in Gastroenterology in 2012, has shown that discontinuing infliximab (Remicade, Janssen) resulted in an approximately 50% clinical relapse in patients with Crohn’s disease by the end of 1 year.